Lavipharm Laboratories

Lavipharm is an integrated Greek pharmaceutical group specializing in the research, development, manufacturing, and marketing of innovative drug delivery systems. The company is globally recognized for its expertise in transdermal patches, oral thin films, and topical formulations, which it develops for both its own portfolio and for international partners. Lavipharm's core therapeutic focus includes pain management, central nervous system disorders, and dermatology. Operating state-of-the-art GMP-certified facilities in Peania, Greece, the company maintains a strong export presence in over 30 countries. Lavipharm is publicly traded on the Athens Stock Exchange and is a key player in the development of hybrid pharmaceutical products.